Puberty and menopause represent the two biological boundaries of female reproductive life. Puberty marks the maturation of the hypothalamic–pituitary–gonadal axis and development of secondary sexual characteristics, whereas natural menopause reflects depletion of ovarian follicular function and is clinically recognized after 12 consecutive months of amenorrhoea without another physiological or pathological cause.[1] The interval between these events is commonly described as the reproductive lifespan.

Changes at either boundary have implications beyond fertility. Early puberty has been associated with psychosocial distress, shorter adult stature, obesity, type 2 diabetes and cardiovascular disease. Premature or early menopause is associated with infertility, vasomotor symptoms, accelerated bone loss and higher cardiometabolic risk. Women experiencing both early menarche and early menopause may have a shortened reproductive lifespan despite early reproductive maturation, but the biological relationship between the two events remains incompletely understood.

Definitions require precision. Precocious puberty is conventionally defined as the appearance of secondary sexual characteristics before eight years in girls. “Early puberty” is a broader epidemiological concept and may refer to puberty occurring earlier than population norms without necessarily meeting the clinical threshold for precocious puberty. Menarche is a late pubertal milestone and should not be used interchangeably with pubertal onset.

Natural menopause usually occurs between 45 and 55 years worldwide.[1] Menopause before 40 years is termed premature menopause. When ovarian activity is intermittent or potentially reversible, especially in younger women, “primary ovarian insufficiency” is generally preferred to “premature menopause.” Menopause between 40 and 44 years is commonly classified as early menopause. Surgical removal of both ovaries and gonadotoxic chemotherapy or radiotherapy produce induced rather than natural menopause and should be considered separately.

This review examines early puberty and early menopause within a unified life-course framework. It emphasizes that reproductive timing is both biologically meaningful and socially patterned, while avoiding the assumption that statistical associations necessarily reflect direct causation.

Secular Trends in Pubertal Timing

The average age of pubertal development has declined in many countries over the past century. A systematic review of studies using breast development as the marker of pubertal onset found that the age at thelarche declined by approximately three months per decade between 1977 and 2013, although trends varied across regions.[2] This finding is important because breast development occurs earlier than menarche and provides a more direct measure of pubertal onset.

The decline in age at menarche has been slower in many high-income countries after earlier improvements in childhood nutrition and health. In low- and middle-income settings, continuing nutritional transition, declining childhood infection and increasing obesity may still be shifting menarcheal timing.

An analysis pooling three rounds of India’s National Family Health Survey found a mean reported age at menarche of 13.49 years. Approximately two-thirds of women reported menarche at 13–14 years, while 17.2% were classified as having early menarche according to the study definition. Younger birth cohorts experienced menarche earlier than older cohorts, indicating a secular decline, although recall and survivor biases must be considered.[3]

Secular trends cannot be attributed to a single exposure. Pubertal timing reflects the interaction of genetic potential with childhood nutrition, adiposity, health, psychosocial conditions and environmental exposures. Improved survival and nutrition may appropriately permit genetic growth potential to be expressed. The public health concern is not that every decline in average pubertal age is pathological, but that rapid or socially patterned changes may signal unhealthy metabolic or environmental conditions.

Determinants of Early Puberty

Childhood adiposity and metabolic signalling

Childhood overweight and rapid weight gain are among the most consistently observed correlates of earlier puberty in girls. Adipose tissue contributes to endocrine signalling through leptin, insulin and aromatization of androgens to oestrogens. A minimum level of energy availability is required for reproductive maturation, and excess energy stores may accelerate this process.

The association is bidirectional. Higher childhood adiposity may advance pubertal development, while pubertal hormonal changes can promote fat accumulation and alter insulin sensitivity. Studies that measure body mass only after puberty begins may therefore overestimate the causal contribution of obesity.

Not every child with obesity enters puberty early, and not every girl with early puberty has excess adiposity. Clinical assessment must therefore consider neurological, genetic and endocrine causes, particularly when development begins before eight years, progresses rapidly or is accompanied by unusual neurological symptoms.

Genetic and familial factors

Pubertal timing is strongly heritable. Maternal age at menarche predicts daughters’ pubertal timing, and genetic variants involved in hypothalamic signalling, energy balance and gonadotropin regulation contribute. Rare activating mutations affecting the hypothalamic–pituitary–gonadal axis can cause central precocious puberty.

Genetics cannot explain rapid changes between successive generations. Secular trends indicate that environmental and social conditions modify inherited susceptibility.

Psychosocial adversity

Childhood adversity, family instability, maltreatment and chronic stress have been associated with earlier pubertal timing in some cohorts. Evolutionary-developmental hypotheses propose that stressful or unpredictable environments may accelerate reproductive maturation. However, adversity is correlated with poverty, obesity, sleep disruption and environmental exposures, making independent effects difficult to establish.

The relationship may also differ by the type and timing of adversity. Associations should not be interpreted as evidence that early puberty is an inevitable consequence of family disruption or that affected children and families are responsible for biological changes.

Endocrine-disrupting chemicals

Concern has increased regarding chemicals capable of interfering with hormonal signalling, including some phthalates, bisphenols, pesticides, flame retardants and persistent organic pollutants. Experimental evidence supports biological plausibility, but human findings are inconsistent. Exposure mixtures, short biological half-lives, changing products and measurement after puberty has already begun complicate causal assessment.

Some chemicals may advance particular pubertal markers, while others delay them. The broad claim that environmental chemicals are responsible for the global decline in pubertal age is therefore not established. Precautionary reduction of unnecessary exposure is reasonable, but stronger prospective research is required.

Clinical and Public Health Consequences of Early Puberty

Early puberty can produce immediate psychosocial difficulties because physical maturation may precede emotional and cognitive readiness. Girls may experience embarrassment, body dissatisfaction, bullying, sexualization and unwanted attention. They may be treated as older than their chronological age while lacking corresponding social autonomy.

Earlier pubertal timing is associated with depression, anxiety and behavioural difficulties, particularly during adolescence.[4] These associations are not uniform and are influenced by family support, peer environments and cultural attitudes towards menstruation and body development. Early maturation should be understood as a period of vulnerability rather than a psychiatric diagnosis.

Rapid skeletal maturation can shorten the period available for linear growth. Children with untreated central precocious puberty may initially be tall for age but attain a shorter adult height because of early epiphyseal closure. Gonadotropin-releasing hormone analogues can pause central puberty and protect adult height in appropriately selected children, but treatment decisions depend on age, progression, predicted height, cause and psychosocial context.

At the population level, early menarche has been associated with adult obesity, insulin resistance, type 2 diabetes and cardiovascular disease. A large UK cohort reported a nonlinear association between age at menarche and vascular disease, with higher coronary risk among women with very early menarche.[5] These findings do not prove that menstruation itself causes later disease. Childhood obesity and socioeconomic adversity may contribute to both earlier menarche and cardiometabolic outcomes.

Early menarche has also been associated with modestly higher risks of breast and endometrial cancers, plausibly through longer lifetime exposure to ovarian hormones. Absolute cancer risk remains determined by many other reproductive, genetic and lifestyle factors. Pubertal timing should therefore contribute to risk awareness rather than generate fatalistic counselling.

Early and Premature Menopause

Natural menopause results from progressive depletion of ovarian follicles. WHO describes 45–55 years as the usual worldwide age range.[1] Menopause before 40 is uncommon but clinically significant; menopause at 40–44 affects a larger group and is also associated with adverse long-term outcomes.

Primary ovarian insufficiency differs from established natural menopause because ovarian activity may occur intermittently. Some affected women ovulate or conceive spontaneously, although fertility is markedly reduced. Using the term “ovarian insufficiency” rather than “failure” more accurately reflects biological variability and may reduce stigma.

Early cessation of menstruation should not automatically be attributed to menopause. Pregnancy, hypothalamic amenorrhoea, hyperprolactinaemia, thyroid disease, polycystic ovary syndrome, uterine pathology and medication effects must be considered. Hormonal contraceptives and hysterectomy can obscure menstrual markers, making retrospective classification difficult.

Causes and Determinants of Early Menopause

Genetic and autoimmune causes

Family history is a strong predictor of age at menopause. Chromosomal disorders, including Turner syndrome and X-chromosome abnormalities, and the fragile-X messenger ribonucleoprotein 1 premutation are established causes of primary ovarian insufficiency. Autoimmune thyroid or adrenal disorders may coexist, although many cases remain idiopathic.

Medical and surgical causes

Bilateral oophorectomy produces immediate surgical menopause. Chemotherapy and pelvic radiotherapy can damage follicles, with risk depending on age, agent, dose and ovarian reserve. Fertility-preservation counselling should therefore occur before gonadotoxic treatment whenever feasible.

Hysterectomy without oophorectomy does not itself constitute menopause, although ovarian function may decline earlier in some women. Studies relying only on absence of menstruation may mistakenly classify women after hysterectomy as naturally menopausal.

Smoking, nutrition and social conditions

Smoking is one of the most consistently identified modifiable predictors of earlier menopause. Toxic constituents of tobacco may accelerate follicular depletion and alter oestrogen metabolism. Associations have also been reported with low socioeconomic position, undernutrition, reproductive history and certain dietary patterns, but causality is less certain.

A recent NFHS-5 analysis estimated premature menopause in 2.2% of Indian women younger than 40 and early menopause in 16.2% of women aged 40–44. Lower education, economic disadvantage, smoking, selected dietary practices and early menarche were associated with earlier menopause.[6] These estimates require careful interpretation because the survey was cross-sectional, menopause was self-reported and women aged 40–44 who had not yet reached menopause remained under observation.

Health Consequences of Early Menopause

Cardiovascular and metabolic health

Earlier menopause is consistently associated with increased cardiovascular risk. In a pooled analysis of more than 300,000 women, compared with menopause at 50–51 years, premature menopause was associated with a 55% higher risk of a first non-fatal cardiovascular event, while menopause at 40–44 years was associated with a 30% higher risk.[7] Associations were strongest before age 60.

Several interpretations are possible. Loss of ovarian oestrogen may contribute to adverse lipid, vascular and body-composition changes. Alternatively, early menopause and cardiovascular disease may share causes, including smoking, inflammation, socioeconomic disadvantage or genetic susceptibility. Observational associations do not establish that replacing oestrogen will eliminate all excess cardiovascular risk.

Skeletal health

Oestrogen restrains bone resorption. Premature loss of ovarian function accelerates bone loss and increases the lifetime risk of osteoporosis and fragility fracture. The younger the age of ovarian insufficiency, the longer the period of exposure to low oestrogen.

Bone-health management includes adequate calcium and vitamin D intake, resistance and weight-bearing activity, avoidance of smoking and assessment for secondary causes. Bone-density testing is appropriate in confirmed primary ovarian insufficiency, but repeated testing should be individualized according to initial findings and treatment adherence.

Table 1. Early Puberty and Early Menopause: Definitions, Determinants, Consequences and Priority Responses

Fertility, sexual and psychological health

Premature menopause may cause infertility at a time when pregnancy is desired or has not yet been considered. Diagnosis can provoke grief, altered self-image, anxiety and relationship stress. Clinical care should include fertility counselling, psychological support and discussion of contraception because intermittent ovarian activity can occur in primary ovarian insufficiency.

Vaginal dryness, dyspareunia, reduced sexual comfort and urinary symptoms may occur. These concerns are frequently neglected, particularly in settings where sexuality is rarely discussed with unmarried or middle-aged women.

Cognitive and neurological outcomes

Observational studies have linked premature surgical or natural menopause with cognitive decline and dementia, but the evidence is less consistent than that for bone and cardiovascular outcomes. Confounding by indication, education, vascular risk and hormone-therapy use complicates interpretation. Cognitive decline should not be presented as inevitable.

Is Early Puberty Linked to Early Menopause?

The hypothesis that earlier puberty accelerates depletion of the ovarian reserve and therefore causes earlier menopause is intuitively appealing but biologically unproven. Follicular depletion occurs continuously from fetal life and is not determined simply by the number of ovulatory cycles.

Some observational studies report associations between early menarche and earlier menopause, while others show weak, nonlinear or no independent relationship after adjustment. Indian NFHS-5 analysis identified early menarche as a correlate of premature and early menopause, but cross-sectional data cannot establish causality.[6]

Shared life-course determinants may explain part of the association. Nutrition, smoking exposure, socioeconomic circumstances, genetics and chronic disease can influence both reproductive milestones. Early menarche may also be recalled more accurately than menopause in younger women, creating differential measurement error.

The combined concept of “reproductive lifespan” is valuable but incomplete. A longer reproductive lifespan may increase cumulative exposure to ovarian hormones and some hormone-sensitive cancers, while a shorter lifespan may increase cardiovascular and skeletal risk. Neither longer nor shorter exposure is universally beneficial. Risk depends on why the reproductive period began or ended at a particular age.

Management of Premature Ovarian Insufficiency and Early Menopause

Women with suspected ovarian insufficiency require confirmation of the diagnosis and evaluation for pregnancy, thyroid disease, hyperprolactinaemia and other causes of amenorrhoea. Depending on age and presentation, assessment may include repeated gonadotropin measurement, chromosomal analysis, fragile-X premutation testing and autoimmune evaluation.

Hormone therapy is generally recommended for women with primary ovarian insufficiency who do not have contraindications, usually until the average age of natural menopause. The purpose extends beyond symptom relief to maintenance of bone, cardiovascular and sexual health.[8] Evidence from hormone therapy initiated in women around the usual menopausal age should not be applied uncritically to young women with pathological oestrogen deficiency.

Treatment should reproduce physiological oestrogen exposure as closely as practical. Women with a uterus require endometrial protection with a progestogen. Individual factors—including thrombosis risk, migraine, cancer history, route preference and need for contraception—must guide therapy.

Hormone therapy for primary ovarian insufficiency is not necessarily contraceptive. Women requiring reliable pregnancy prevention may need an additional or alternative method. Fertility counselling should be accurate and sensitive: spontaneous pregnancy is possible but uncommon, and donor-oocyte assisted reproduction remains the most effective option for many affected women.

Public Health Significance

Early puberty and early menopause are commonly treated as separate paediatric and adult gynaecological issues. A life-course approach reveals shared connections with nutrition, obesity, smoking, environmental exposures, social adversity and noncommunicable disease.

Pubertal timing can identify girls who may benefit from psychosocial support and long-term metabolic prevention. Menopausal timing can identify women requiring earlier cardiovascular and bone-health assessment. Neither event should be used as a deterministic screening test, but both can enrich clinical risk assessment.

The conditions also expose gaps in gender-sensitive health systems. Menstrual education often begins only after menarche, leaving early-maturing girls unprepared. At the other end of reproductive life, menopause remains absent from many primary-care and reproductive-health programmes. WHO has emphasized that menopause-related counselling and treatment should form part of universal health coverage.[1]

Indian Perspective

India is undergoing simultaneous nutritional and demographic transitions. Childhood undernutrition persists, but childhood and adolescent obesity are increasing. These divergent exposures may produce substantial heterogeneity in pubertal timing across socioeconomic groups and regions.

NFHS-based research indicates that the average age at menarche is declining and that early menarche is socially patterned.[3] However, national surveys record recalled age in whole years and do not assess breast or pubic-hair development. They therefore cannot reliably estimate clinical precocious puberty.

Evidence on menopause similarly depends heavily on menstrual histories collected from women younger than 50. Women using hormonal contraception, those with hysterectomy and women with secondary amenorrhoea may be difficult to classify. The reported 2.2% prevalence of premature menopause and 16.2% prevalence of early menopause in NFHS-5 provide an important signal but should not be interpreted as definitive clinical prevalence.[6]

India’s reproductive and child-health services offer possible platforms for improvement. School health programmes can include age-appropriate puberty and menstrual education. Paediatric and adolescent services should establish referral criteria for suspected precocious puberty. Ayushman Arogya Mandirs and NCD clinics could incorporate menopause history, blood pressure, diabetes risk, smoking status and bone-health counselling.

Menopause care must not be reduced to commercial hormone testing or indiscriminate supplementation. Public-sector services need clear diagnostic pathways, access to appropriate hormone therapy, cancer and thrombosis risk assessment, and referral for fertility and endocrine care.

Recent Advances

Recent puberty research increasingly uses longitudinal cohorts, growth trajectories and objective pubertal staging rather than relying solely on recalled menarche. Omics research and genetic analyses are identifying pathways connecting energy balance, neuroendocrine signalling and reproductive maturation. These advances are scientifically valuable but have not yet replaced clinical assessment.

Environmental epidemiology is moving towards mixture analysis because children encounter multiple endocrine-active compounds rather than isolated chemicals. Repeated exposure measurements before pubertal onset are necessary to reduce reverse causation.

For early menopause, improved survivorship after childhood and young-adult cancer has increased attention to fertility preservation and long-term ovarian health. Oocyte or embryo cryopreservation is established for selected patients, while ovarian-tissue preservation is increasingly used in specialist settings.

Digital symptom tracking and direct-to-consumer hormone testing are expanding. Symptom diaries may support care, but single measurements of anti-Müllerian hormone do not reliably predict the exact age of natural menopause for an individual woman. Commercial claims that ovarian-reserve tests can forecast reproductive lifespan should be treated cautiously.

Challenges and Limitations

Definitions vary across studies. Early menarche may mean before 10, 11, 12 or 13 years, while early puberty may be based on breast, pubic-hair or growth markers. Menopause studies differ in whether they include surgical or medically induced cases.

Recall is a major limitation. Age at menarche is often remembered reasonably well but can still be rounded. Age at menopause may be difficult to recall after many years, particularly when cycles were irregular or altered by contraception.

Residual confounding affects long-term outcome studies. Childhood adiposity may both advance puberty and cause adult metabolic disease. Smoking may accelerate menopause and independently cause cardiovascular disease. Adjustment reduces but does not eliminate these concerns.

There is also a risk of medicalization. Not every girl maturing at the earlier end of normal requires treatment, and menopause itself is not a disease. Intervention is justified when timing reflects pathology, symptoms impair well-being or the transition creates preventable long-term risk.

Future Directions

Prospective cohorts should measure childhood growth, body composition, pubertal staging, environmental exposures and psychosocial conditions before puberty begins. Follow-up into adulthood is needed to determine which associations are causal and modifiable.

Menopause research should distinguish natural, surgical and treatment-induced menopause and include women beyond conventional reproductive-age surveys. Biomarkers and clinical histories should be combined where feasible.

India requires regionally representative longitudinal studies of pubertal development and menopause. Existing national surveys could improve measurement by recording menstrual regularity, reason for cessation, hysterectomy and oophorectomy history, cancer treatment and menopausal symptoms.

Preventive programmes should address childhood obesity through supportive food and activity environments rather than weight stigma. Tobacco prevention may contribute to reducing early menopause as well as broader disease. Survivors of cancer and women undergoing pelvic surgery require fertility and hormonal counselling before treatment.

Clinical guidelines should establish clear pathways from primary care to paediatric endocrinology, gynaecology and reproductive medicine. Public communication must explain that reproductive timing modifies risk but does not determine an individual woman’s future health.

Early puberty and early menopause are important markers of health across the female life course. Their timing reflects interactions among genetics, nutrition, metabolism, social conditions, medical treatment and environmental exposure.

Early puberty is associated with psychosocial and cardiometabolic vulnerability, but much of the long-term risk may be shared with childhood obesity and adversity. Premature and early menopause are more consistently linked with infertility, bone loss and cardiovascular disease, although shared causes also contribute.

Evidence that early puberty directly produces early menopause remains insufficient. The two events should be considered connected components of reproductive history rather than endpoints in a simple causal chain.

A life-course public health response should prepare girls for puberty, identify pathological development promptly, prevent childhood metabolic risk, recognize ovarian insufficiency early and ensure access to fertility, hormonal, cardiovascular and bone-health care. Reproductive milestones are not merely private biological events; they are clinically useful indicators of population health and opportunities for prevention.

1. World Health Organization. Menopause [Internet]. Geneva: World Health Organization; 2024 Oct 16 [cited 2026 Aug 6]. Available from: https://www.who.int/news-room/fact-sheets/detail/menopause
2. Eckert-Lind C, Busch AS, Petersen JH, Biro FM, Butler G, Bräuner EV, et al. Worldwide secular trends in age at pubertal onset assessed by breast development among girls: a systematic review and meta-analysis. JAMA Pediatr. 2020;174(4):e195881. doi:10.1001/jamapediatrics.2019.5881.
3. Meher T, Sahoo H. Secular trend in age at menarche among Indian women. Sci Rep. 2024;14(1):5398. doi:10.1038/s41598-024-55657-7.
4. Sun Y, Liu H, Mu C, Liu P, Hao C, Xin Y. Early puberty: a review on its role as a risk factor for metabolic and mental disorders. Front Pediatr. 2024;12:1326864. doi:10.3389/fped.2024.1326864.
5. Canoy D, Beral V, Balkwill A, Wright FL, Kroll ME, Reeves GK, et al. Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort. Circulation. 2015;131(3):237-244. doi:10.1161/CIRCULATIONAHA.114.010070.
6. Kundu S, Acharya SS. Exploring the triggers of premature and early menopause in India: a comprehensive analysis based on National Family Health Survey, 2019–2021. Sci Rep. 2024;14(1):3040. doi:10.1038/s41598-024-53536-9.
7. Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual participant data. Lancet Public Health. 2019;4(11):e553-e564. doi:10.1016/S2468-2667(19)30155-0.
8. Committee on Adolescent Health Care. Committee Opinion No. 605: Primary ovarian insufficiency in adolescents and young women. Obstet Gynecol. 2014;124(1):193-197. doi:10.1097/01.AOG.0000451757.51964.98.
9. Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015;18(4):483-491. doi:10.3109/13697137.2015.1020484.
10. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360(6):606-614. doi:10.1056/NEJMcp0808697.